Published in Am J Pathol on September 01, 1997
Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol (2006) 2.06
Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy (2010) 1.41
Sputum hyaluronan and versican in severe eosinophilic asthma. Int Arch Allergy Immunol (2012) 0.84
IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing. J Invest Dermatol (2016) 0.83
Induction of bone-marrow eosinophilia in mice submitted to surgery is dependent on stress-induced secretion of glucocorticoids. Br J Pharmacol (2004) 0.82
Increased blood clotting, microvascular density, and inflammation in eotaxin-secreting tumors implanted into mice. Am J Pathol (2004) 0.80
Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment. Transfus Med Hemother (2016) 0.78
The Regulatory Function of Eosinophils. Microbiol Spectr (2016) 0.75
Thermal injury increases the number of eosinophil progenitors in rat spleen and bone marrow. Inflammation (2001) 0.75
Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science (1989) 4.57
Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science (1986) 3.52
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med (1988) 3.50
The immunobiology of eosinophils. N Engl J Med (1991) 2.58
Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol (1989) 2.54
Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci U S A (1990) 2.37
Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy. Clin Exp Immunol (1976) 2.10
Human eosinophils express transforming growth factor alpha. J Exp Med (1990) 2.04
Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol (1990) 1.88
Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med (1995) 1.40
Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis (1993) 1.39
Depletion of eosinophils by anti-IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection. J Immunol (1992) 1.29
Metabolic heterogeneity of eosinophils from normal and hypereosinophilic patients. Blood (1981) 1.27
Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model. Lab Invest (1990) 1.25
Type-specific collagen degradation by eosinophils. Biochem J (1982) 1.15
The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds. Am J Pathol (1991) 1.15
A light microscopical study of healing incised dermal wounds in rats, with special reference to eosinophil leucocytes and to the collagenous fibres of the periwound areas. Br J Exp Pathol (1977) 1.14
Eosinophils, neutrophils, and venular gaps in the airway mucosa at epithelial removal-restitution. Am J Respir Crit Care Med (1996) 1.13
Sequential expression of transforming growth factors alpha and beta 1 by eosinophils during cutaneous wound healing in the hamster. Am J Pathol (1993) 1.08
Lack of TGF-alpha and TGF-beta 1 synthesis by human eosinophils in chronic oral ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 0.99
Production of transforming growth factor alpha by hamster eosinophils. Am J Pathol (1990) 0.96
Salivary EGF regulates eosinophil-derived TGF-alpha expression in hamster oral wounds. Am J Physiol (1996) 0.86
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol (1982) 5.44
BioMart Central Portal: an open database network for the biological community. Database (Oxford) (2011) 3.03
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol (1998) 2.71
Specific cellular immune unresponsiveness in human filariasis. Immunology (1977) 2.23
Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology (1996) 2.18
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
Fractured laryngeal mask airway (LMA). Can J Anaesth (2000) 2.12
Restoring sensation after trigeminal nerve injury: a review of current management. J Am Dent Assoc (1992) 2.05
Human eosinophils express transforming growth factor alpha. J Exp Med (1990) 2.04
The pharmacologic profile of fluoxetine. J Clin Psychiatry (1985) 2.04
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med (1989) 1.97
A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci (1974) 1.93
Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci U S A (1983) 1.91
Bronchoconstrictor effects of leukotriene C in humans. Science (1982) 1.91
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology (2001) 1.88
Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest (2000) 1.85
Laser capture microdissection-generated target sample for high-density oligonucleotide array hybridization. Biotechniques (2000) 1.68
Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene (2001) 1.67
A quantitative assessment of how Canadian intensivists believe they utilize oxygen in the intensive care unit. Crit Care Med (1999) 1.66
Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol (1993) 1.65
Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65
Eosinophilia. J Allergy Clin Immunol (1984) 1.65
Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am (1993) 1.63
Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci U S A (1989) 1.62
CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med (1991) 1.58
Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol (1993) 1.57
Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med (2002) 1.54
IL-4 directly modulates function of a model human intestinal epithelium. J Immunol (1994) 1.53
Saliva: diagnostics and therapeutic perspectives. Oral Dis (2010) 1.50
Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem (1989) 1.49
A comparison of peribulbar and retrobulbar anesthesia for vitreoretinal surgical procedures. Arch Ophthalmol (1995) 1.49
Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol (1997) 1.45
Human saliva proteome and transcriptome. J Dent Res (2006) 1.43
Comparative human salivary and plasma proteomes. J Dent Res (2010) 1.41
Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes. Cancer Res (1999) 1.40
Hepatitis G virus infection in hemodialysis patients and the effects of interferon treatment. Am J Gastroenterol (1997) 1.38
The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs). J Immunol (1980) 1.36
Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. J Biol Chem (1992) 1.35
Secretory antibody response to respiratory syncytial virus infection. Am J Dis Child (1981) 1.34
Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis (2008) 1.33
Effects of antibiotic ionophore, A23187, on oxidative phosphorylation and calcium transport of liver mitochondria. Arch Biochem Biophys (1973) 1.33
Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J Immunol (2001) 1.33
A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine. J Pharmacol Exp Ther (1975) 1.32
Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J Exp Med (1997) 1.32
Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells. Blood (2000) 1.31
Release of C8 binding protein (C8bp) from the cell membrane by phosphatidylinositol-specific phospholipase C. Blood (1988) 1.30
Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies. Am J Pathol (1998) 1.30
Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Proc Natl Acad Sci U S A (1980) 1.30
Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J (1995) 1.29
Rapid diagnosis of parainfluenza virus infection in children. J Clin Microbiol (1982) 1.28
Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy (2008) 1.26
Human eosinophils express functional interleukin 2 receptors. J Clin Invest (1991) 1.26
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc Natl Acad Sci U S A (1996) 1.26
The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am Rev Respir Dis (1993) 1.25
Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood (1991) 1.24
Indeterminate human immunodeficiency virus type 1 western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation. J Infect Dis (1991) 1.24
Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest (1993) 1.23
Identification of hepatitis B virus polypeptides encoded by the entire pre-s open reading frame. J Virol (1985) 1.23
Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J Biol Chem (2001) 1.21
Antiparasitic drugs. N Engl J Med (1996) 1.20
Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol (1996) 1.20
Fluoxetine, a selective inhibitor of serotonin uptake. Med Res Rev (1991) 1.20
Endemic filariasis on a Pacific Island. II. Immunologic aspects: immunoglobulin, complement, and specific antifilarial IgG, IgM, and IgE antibodies. Am J Trop Med Hyg (1982) 1.19
The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin. J Biol Chem (1995) 1.18
A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J Pharmacol Exp Ther (1982) 1.18
New structural concepts for narcotic antagonists defined in a 4-phenylpiperidine series. Nature (1978) 1.18
Phosphatidylinositol-specific phospholipase C, a possible virulence factor of Staphylococcus aureus. J Clin Microbiol (1989) 1.17
Prothrombotic and vascular risk factors in NAION. Ophthalmology (2000) 1.17
The efficacy and resource utilization of remifentanil and fentanyl in fast-track coronary artery bypass graft surgery: a prospective randomized, double-blinded controlled, multi-center trial. Anesth Analg (2001) 1.17
Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med (1989) 1.16
Predictors of hospital mortality and mechanical ventilation in patients with cervical spinal cord injury. Can J Anaesth (1998) 1.15
The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds. Am J Pathol (1991) 1.15
Familial predisposition to filarial infection--not linked to HLA-A or-B locus specificities. Acta Trop (1981) 1.15
Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology (2000) 1.14
The regulatory and effector roles of eosinophils. Adv Immunol (1979) 1.14
Ultrastructural immunogold localization of tumor necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. J Histochem Cytochem (1993) 1.14
Inhibition of serotonin reuptake. Fed Proc (1977) 1.11
Parainfluenza virus bronchiolitis. Epidemiology and pathogenesis. Am J Dis Child (1986) 1.11
Bancroftian filariasis and ivermectin. N Engl J Med (1990) 1.11
Fluorescent staining for leukocyte chemotaxis. Eosinophil-specific fluorescence with aniline blue. J Immunol Methods (1988) 1.11
Natural history of parainfluenza virus infection in childhood. J Pediatr (1982) 1.11
Epidermal growth factor receptor (EGFR) biology and human oral cancer. Histol Histopathol (1999) 1.11
Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J Histochem Cytochem (1992) 1.10
IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils. J Immunol (1998) 1.10
IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol (1996) 1.10
Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors. Biochem Pharmacol (1983) 1.10
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein. Mol Cell Biol (2000) 1.09
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors. J Pharmacol Exp Ther (1994) 1.09
Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and 3T3 fibroblasts. Int Arch Allergy Immunol (1994) 1.09
The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA (1997) 1.09